In addition to decreased tumour size, CUDC‐907 administration induced higher expressions of cleaved Caspase 3 and lower expressions of Ki67, indicating promoted cell apoptosis and suppressed cell proliferation (Figure 7F). This evidence concerns the gene CASP3 and neoplasm.